STOCK TITAN

Johnson & Johnson (NYSE: JNJ) chief sells 48,480 company shares

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Johnson & Johnson CEO and chairman Joaquin Duato reported selling 48,480 shares of common stock on August 5, 2026, in two open-market transactions at weighted average prices of $258.056 and $258.739. He continues to report indirect holdings of 1,018 shares via a 401k plan and 30,852 shares held by his spouse.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Duato Joaquin
Role CEO and Chairman of the Board
Sold 48,480 shs ($12.52M)
Type Security Shares Price Value
Sale Common Stock F1 41,957 $258.056 $10.83M
Sale Common Stock F2 6,523 $258.739 $1.69M
holding Common Stock F3 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 275,967 shares (Direct); Common Stock — 1,018 shares (Indirect, By 401k); Common Stock — 30,852 shares (Indirect, By spouse)
Footnotes (3)
  1. F1. This transaction was executed in multiple trades at prices ranging from $257.53 to $258.505. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. F2. This transaction was executed in multiple trades at prices ranging from $258.535 to $259.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2026).
Shares sold, first transaction 41,957 shares Open-market sale of Johnson & Johnson common stock on August 5, 2026
Weighted average price, first transaction $258.056 per share Weighted average sale price for 41,957-share transaction
Shares sold, second transaction 6,523 shares Second open-market sale of common stock on August 5, 2026
Weighted average price, second transaction $258.739 per share Weighted average sale price for 6,523-share transaction
Total shares sold 48,480 shares Aggregate Johnson & Johnson common shares sold by Joaquin Duato on August 5, 2026
Indirect 401k holdings after transactions 1,018 shares Common shares held indirectly via Johnson & Johnson Savings Plan; includes dividend reinvestment as of 7/31/2026
Indirect spouse holdings after transactions 30,852 shares Common shares held indirectly by spouse following reported transactions
Price range, first transaction $257.53–$258.505 per share Range of individual trade prices for 41,957-share sale
Price range, second transaction $258.535–$259.10 per share Range of individual trade prices for 6,523-share sale
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
dividend reinvestment financial
"Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund..."
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
Johnson & Johnson Savings Plan financial
"Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan..."
401k financial
"Common Stock held indirectly, nature of ownership described as "By 401k"."
An employer-sponsored retirement savings plan in the United States that lets workers set aside part of their paycheck into investments with tax advantages; some plans also include employer matching contributions, which is like free money added to your savings. It matters to investors because 401(k) balances represent a large pool of household retirement assets that influence personal financial security, investor behavior, and long-term demand for stocks and bonds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock transaction did JNJ CEO Joaquin Duato report?

Joaquin Duato reported selling 48,480 shares of Johnson & Johnson common stock on August 5, 2026. The sale occurred in two open-market transactions at weighted average prices of $258.056 and $258.739, as disclosed in the Form 4 filing.

How many JNJ shares did Joaquin Duato sell in each transaction?

He sold 41,957 shares in one transaction and 6,523 shares in another, both on August 5, 2026. Each transaction involved Johnson & Johnson common stock sold in the open market at separate weighted average prices disclosed in the report.

At what prices were Joaquin Duato’s JNJ share sales executed?

The reported weighted average sale prices were $258.056 for 41,957 shares and $258.739 for 6,523 shares. Footnotes state both were executed in multiple trades within price ranges from $257.53–$258.505 and $258.535–$259.10, respectively.

Does Joaquin Duato still hold Johnson & Johnson shares after these sales?

Yes. He reports indirect holdings of 1,018 shares of Johnson & Johnson common stock via a 401k plan and 30,852 shares held indirectly by his spouse. The 401k figure includes shares from dividend reinvestment as of the plan’s July 31, 2026 reporting date.

Were Joaquin Duato’s JNJ stock sales executed in multiple trades?

Yes. Footnotes explain each reported sale was executed in multiple trades within specified price ranges. The Form 4 reports a single weighted average sale price for each transaction and offers to provide full trade detail upon request to regulators or shareholders.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duato Joaquin

(Last)(First)(Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NEW JERSEY 08933

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and Chairman of the Board
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/05/2026S41,957D$258.056(1)282,490D
Common Stock08/05/2026S6,523D$258.739(2)275,967D
Common Stock1,018(3)IBy 401k
Common Stock30,852IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $257.53 to $258.505. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2. This transaction was executed in multiple trades at prices ranging from $258.535 to $259.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2026).
Remarks:
/s/ Joleen Morgan, as attorney-in-fact for Joaquin Duato08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)